PFE vs TSLA: Which Is the Better Buy?
Side-by-side comparison of Pfizer Inc. and Tesla, Inc. — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-04-11.
Pfizer Inc. · Healthcare
$26.91
+30.1% upside to fair value
Med Conviction
Grade B+
VS
Tesla, Inc. · Consumer Cyclical
$343.23
-5.3% upside to fair value
Low Conviction
Grade D
QuantHub Verdict
PFE has more upside to fair value
(+30.1%).
PFE trades at a lower forward P/E
(9.5x).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
PFE |
TSLA |
| Current Price |
$26.91 |
$343.23 |
| Fair Value Estimate |
$35.00 |
$325.00 |
| Upside to Fair Value |
+30.1%
|
-5.3%
|
| Market Cap |
$153.0B |
$1,287.9B |
| Forward P/E |
9.5x
|
205.5x
|
| EV / EBITDA |
13.8x
|
108.8x
|
| Price / Sales |
2.4x
|
13.6x
|
| Price / FCF |
16.8x
|
207.1x
|
| Revenue Growth YoY |
-1.6%
|
-2.9%
|
| Gross Margin |
70.3%
|
18.0%
|
| Operating Margin |
24.7%
|
4.6%
|
| Return on Equity |
9.0%
|
4.8%
|
| Dividend Yield |
6.4% |
0% |
| FCF Yield |
5.9%
|
0.48%
|
| Analyst Consensus |
Hold
|
—
|
Investment Thesis
Pfizer remains the world's largest traditional pharmaceutical company by non-COVID revenue, generating $62.6B in 2025 sales across oncology, cardiovascular, immunology, and vaccines. The stock trades at a P/S of 2.44x, still well below the 5-year median of 3.10x, driven by post-COVID revenue normalization, a $17-18B patent cliff spanning 2026-2028, and $61.6B in acquisition-related debt from Seag…
Tesla remains the most polarizing stock in markets. The core auto business is deteriorating: FY2025 revenue fell 2.9% to $94.8B, net income dropped 46.8% to $3.8B, and Q4 deliveries declined 15.6% YoY to 418K units. Yet the stock trades at 13.6x TTM P/S (near 5yr highs) on the optionality of Cybercab robotaxis launching April 2026, FSD reaching unsupervised status in Austin, and Optimus humanoid …
Accumulation Zones
| Metric |
PFE |
TSLA |
| Zone Low |
$25.00 |
$244.00 |
| Zone High |
$29.00 |
$276.00 |
| In Buy Zone? |
Yes
|
No
|